The complete TECO Medical reagent portfolio — clotting tests, chromogenic and immunological assays, controls, calibrators, and factor deficient plasmas.
For professional use only
TEClot PT-S
Clotting test for the quantitative determination of prothrombin time (PT) in citrated human plasma according to Quick. Sensitive to all intrinsic factors II, V, VII, X and fibrinogen.
Lyophilized reagent, High sensitivity (ISI~1,0), Excellent stability.
TEClot PT-B
Clotting test for the quantitative determination of prothrombin time (PT) in citrated human plasma or whole blood according to Owren. Sensitive only to factor II, VII,X.
Lyophilized reagent, Traceable to WHO IRP67/40, through RBT90, Not influenced by patients with Factor V or Fibrinogen levels, Insensitive to LA, Excellent precision between INR 1-6. Kit contains: 5x10ml PT-B , 5x5ml Diluent, 5x5ml CaCl2
TEClot APTT-S
Clotting test for quantitative determination of the Activated Partial Thromboplastin Time (APTT) in citrated human plasma using silicate as contact activator for factor XII.
Ready to use (liquid), Near colloidal silicat contact activator, Insensitive for LA, Highly sensitive UFH, Excellent factor sensitivity
TEClot TT
Clotting test for quantitative determination of the Thrombin Time (TT) in citrated human plasma.
Lyophilized reagent, High sensitivity to UFH and Dabigatran, Excellent stability.
TEClot FIB
intended for the quantitative determination of Fibrinogen concentration in human citrated plasma according to Clauss.
Lyophilized reagent, Excellent stability, ~ 100 UNIH/ml, Linearity up to 800 mg/dL (8 g/L)
Red D-Dimer
Exclusion (diagnostic) of deep vein thrombosis (DVT) or pulmonary embolism (PE). Immunoturbidimetric reagent for the quantitative determination of D-Dimer concentration in human plasma on optical Coagulometer at 600-800nm.
Ready to use (liquid), Kit contains: 3x4 ml Latex, 3x7 ml Reaction Buffer
Blue D-Dimer
Exclusion (diagnostic) of deep vein thrombosis (DVT) or pulmonary embolism (PE). Immunoturbidimetric reagent for the quantitative determination of D-Dimer concentration in human plasma on optical Coagulometer at 400-470nm.
Ready to use (liquid). Kit contains: 1x5 ml Latex, 1x7 ml Reaction Buffer
TECal N
Use as a calibrator or normal control for following coagulation tests: PT, APTT, Thrombintime, Fibrinogen, Factors: II, V, VII, VIII, IX, X, XI, XII, Antithrombin, Protein-C, free Protein-S, D-Dimer
Human plasma, Lyophilized, Long shelf life, Excellent stability
TECal DD
Use as calibrator of D-Dimer immunoassays, Recommended for calibration of D-Dimer reagent
Human plasma, Lyophilized, Long shelf life, Excellent stability
TEControl N
Use as a normal control for following coagulation tests: PT,APTT,Thrombintime and Fibrinogen.
Human plasma, Lyophilized, Long shelf life, Excellent stability
TEControl A
Use as a normal control for following coagulation tests: PT,APTT,Thrombintime and Fibrinogen.
Human plasma, Lyophilized, Long shelf life, Excellent stability
TEControl A Plus
Use as abnormal normal control for following coagulation tests: PT, APTT, Thrombintime, Fibrinogen,Factors: II, V, VII, VIII, IX, X, XI, XII, Antithrombin, Protein-C, free Protein-S, D-Dimer
Human plasma, Lyophilized, Long shelf life, Excellent stability
Deficient Plasma Factor II
Screening of bleeding disorders caused by factor II deficiency. This product is intended for the quantitative determination of factor II in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Deficient Plasma Factor V
Screening of bleeding disorders caused by factor V deficiency. This product is intended for the quantitative determination of factor V in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Deficient Plasma Factor VII
Screening of bleeding disorders caused by factor VII deficiency. This product is intended for the quantitative determination of factor VII in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Deficient Plasma Factor VIII
Screening of bleeding disorders caused by factor VIII deficiency. This product is intended for the quantitative determination of factor VIII in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Deficient Plasma Factor IX
Screening of bleeding disorders caused by factor IX deficiency. This product is intended for the quantitative determination of factor IX in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Deficient Plasma Factor X
Screening of bleeding disorders caused by factor X deficiency. This product is intended for the quantitative determination of factor X in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Deficient Plasma Factor XI
Screening of bleeding disorders caused by factor XI deficiency. This product is intended for the quantitative determination of factor XI in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Deficient Plasma Factor XII
Screening of bleeding disorders caused by factor XII deficiency. This product is intended for the quantitative determination of factor XII in human plasma by clotting assay.
Immunodepleted, Lyophilized (dried)
Calcium Chloride 0.025M
general laboratory use product, suitable to add calcium ions to the citrated human plasma samples, recommended to combine with TEClot APTT-S.
Ready to use (liquid), for general laboratory use only. Not registered as an In Vitro Diagnostic (IVD).
IBS Buffer
general laboratory use product, suitable for dilution of citrated human plasma samples, recommended to combine with TEClot FIB reagent and Factor reagents
Ready to use (liquid), for general laboratory use only. Not registered as an In Vitro Diagnostic (IVD).
Owren's Buffer
general laboratory use product, suitable for dilution of citrated human plasma samples, recommended to prepare plasma dilutions for hemostatis tests.
Ready to use (liquid), for general laboratory use only. Not registered as an In Vitro Diagnostic (IVD).
Ongoing certifications and quality assurance are self-evident. Manufacturing facilities operate under strict DIN EN ISO 13485 guidelines, ensuring highest medical device standards.
Innovation and further development is our corporate identity. Dedicated R&D teams constantly innovating to bring advanced diagnostic capabilities to modern clinical environments.
Decades of expertise in hemostasis with a robust international distribution network, providing reliable support.